Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

EXG: Ready For The MRCP Podcast

Ep 3. MRCP Cardiology - Valve Disease

17 Jul 2025

Description

Episode 3 – Valvular Heart Disease: 5 MRCP Questions ExplainedIn Episode 3, Dr. Alistair James explores one of cardiology’s most clinically rich and exam-relevant topics: valvular heart disease. From the classic signs of aortic stenosis to the nuanced management of mitral regurgitation, this episode walks you through 5 MRCP-style questions that cover diagnosis, clinical features, investigations, and guideline-driven management.Whether you’re struggling to remember murmur characteristics or need clarity on when to refer for surgery, this episode offers high-yield insights—perfectly tailored for busy doctors revising on the go.✅ Topics Covered:Aortic stenosis, aortic regurgitation, mitral stenosis, and mitral regurgitationMurmur timing and auscultation findingsIndications for echo and referral to cardiologySurgical vs. medical management approachesKey updates from guidelines (as of July 2025)🎓 Sponsored by EXG LearningNeed to brush up on ECGs while revising for the MRCP? EXG Learning is your go-to online platform for interactive ECG tutorials, step-by-step video explanations, and practical case-based learning. Whether you're preparing for exams or building clinical confidence, EXG makes ECG learning clear, structured, and effective.Start your ECG journey today at www.exg-learning.com.🩺 Disclaimer:This podcast is intended for educational purposes only and is not a substitute for professional clinical guidance. All questions and answers discussed reflect MRCP-level knowledge and are based on the guidelines and best practices available as of July 2025.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.